Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO)
INR 39.16
(0.72%)
INR 39.16
(0.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 717.63 Million INR | -33.75% |
| 2022 | 623.12 Million INR | -17.98% |
| 2021 | 759.68 Million INR | 28.14% |
| 2020 | 592.85 Million INR | 21.12% |
| 2019 | 489.46 Million INR | -14.82% |
| 2018 | 574.65 Million INR | 14.36% |
| 2017 | 502.49 Million INR | -5.62% |
| 2016 | 532.39 Million INR | -5.92% |
| 2015 | 565.91 Million INR | 8.69% |
| 2014 | 520.66 Million INR | 11.85% |
| 2013 | 465.48 Million INR | 1.04% |
| 2012 | 460.69 Million INR | 0.0% |
| 2009 | -194.25 Million INR | 83.6% |
| 2008 | -1.18 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 92.84 Million INR | -42.45% |
| 2023 Q2 | 165.63 Million INR | 25.44% |
| 2023 Q3 | 108.36 Million INR | -34.58% |
| 2023 Q4 | 161.32 Million INR | 48.87% |
| 2023 FY | 412.82 Million INR | -33.75% |
| 2023 Q1 | 132.04 Million INR | -6.45% |
| 2022 Q2 | 158.15 Million INR | -4.38% |
| 2022 FY | 623.12 Million INR | -17.98% |
| 2022 Q1 | 165.39 Million INR | 44.92% |
| 2022 Q3 | 158.42 Million INR | 0.17% |
| 2022 Q4 | 141.15 Million INR | -10.9% |
| 2021 Q4 | 114.13 Million INR | -39.79% |
| 2021 Q3 | 189.56 Million INR | -22.28% |
| 2021 FY | 759.68 Million INR | 28.14% |
| 2021 Q2 | 243.89 Million INR | 14.99% |
| 2021 Q1 | 212.09 Million INR | 48.0% |
| 2020 Q4 | 143.31 Million INR | -12.22% |
| 2020 FY | 592.85 Million INR | 21.12% |
| 2020 Q3 | 163.26 Million INR | -5.79% |
| 2020 Q2 | 173.3 Million INR | 53.4% |
| 2020 Q1 | 112.97 Million INR | 1.9% |
| 2019 Q1 | 120.1 Million INR | -1.54% |
| 2019 FY | 489.46 Million INR | -14.82% |
| 2019 Q3 | 128.87 Million INR | -0.58% |
| 2019 Q4 | 110.87 Million INR | -13.97% |
| 2019 Q2 | 129.62 Million INR | 7.92% |
| 2018 Q3 | 162.62 Million INR | 7.8% |
| 2018 Q2 | 150.86 Million INR | 8.39% |
| 2018 Q1 | 139.18 Million INR | 18.12% |
| 2018 Q4 | 121.98 Million INR | -24.99% |
| 2018 FY | 574.65 Million INR | 14.36% |
| 2017 FY | 502.49 Million INR | -5.62% |
| 2017 Q4 | 117.83 Million INR | -18.08% |
| 2017 Q3 | 143.84 Million INR | 19.85% |
| 2017 Q2 | 120.01 Million INR | -5.82% |
| 2017 Q1 | 127.43 Million INR | 0.0% |
| 2016 FY | 532.39 Million INR | -5.92% |
| 2015 FY | 565.91 Million INR | 8.69% |
| 2014 FY | 520.66 Million INR | 11.85% |
| 2013 FY | 465.48 Million INR | 1.04% |
| 2012 FY | 460.69 Million INR | 0.0% |
| 2009 FY | -194.25 Million INR | 83.6% |
| 2008 FY | -1.18 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ANG Lifesciences India Limited | 232.73 Million INR | -208.352% |
| Add-Shop E-Retail Limited | 224.09 Million INR | -220.235% |
| Bacil Pharma Limited | -19.95 Thousand INR | 3597282.957% |
| BDH Industries Limited | 175.55 Million INR | -308.782% |
| Beryl Drugs Limited | 108.5 Million INR | -561.399% |
| Cian Healthcare Limited | 113.16 Million INR | -534.135% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -3804.026% |
| Concord Drugs Limited | 116.7 Million INR | -514.922% |
| Deccan Health Care Limited | 221.57 Million INR | -223.886% |
| DECIPHER LABS LIMITED | 331.34 Million INR | -116.587% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | -407.491% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 44.028% |
| Hindustan Bio Sciences Limited | 3.14 Million INR | -22752.952% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 35.248% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | -1742.885% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 50.06% |
| Panchsheel Organics Limited | 356.44 Million INR | -101.33% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | -542.101% |
| Parnax Lab Limited | 552.1 Million INR | -29.982% |
| Makers Laboratories Limited | 308.54 Million INR | -132.587% |
| Medi-Caps Limited | 68.09 Million INR | -953.924% |
| MedPlus Health Services Limited | 12.33 Billion INR | 94.181% |
| Phaarmasia Limited | 38.89 Million INR | -1745.302% |
| Parmax Pharma Limited | 99.31 Million INR | -622.572% |
| Patidar Buildcon Limited | -26 Thousand INR | 2760246.154% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | -243.569% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 176858.128% |
| Trident Lifeline Limited | 119.08 Million INR | -502.642% |
| Tyche Industries Limited | 290.84 Million INR | -146.742% |
| Vivanza Biosciences Limited | 19.38 Million INR | -3601.645% |
| PRAVEG LIMITED | 266.99 Million INR | -168.784% |
| Smruthi Organics Limited | 324.76 Million INR | -120.974% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | -987.133% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | -98.369% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 40.173% |
| Transchem Limited | -8.96 Million INR | 8103.992% |
| Trinity League India Limited | 1.23 Million INR | -58149.838% |
| Vikram Thermo (India) Limited | 443.73 Million INR | -61.727% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -7062.056% |
| Sunil Healthcare Limited | 247.86 Million INR | -189.527% |
| Syschem (India) Limited | 569.04 Million INR | -26.112% |
| Zenith Healthcare Limited | 46.17 Million INR | -1454.204% |
| Zenlabs Ethica Limited | 147.75 Million INR | -385.698% |
| Mercury Laboratories Limited | 279.39 Million INR | -156.859% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | -546.69% |
| Vasundhara Rasayans Limited | 207.68 Million INR | -245.545% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 589.268% |
| Roopa Industries Limited | 72.95 Million INR | -883.699% |
| PANJON LTD. | 33.77 Million INR | -2024.509% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 1085.523% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 4129.41% |
| Anuh Pharma Limited | 1.6 Billion INR | 55.244% |
| Crestchem Limited | 51.53 Million INR | -1292.454% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 9754.756% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | -106.75% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 0.976% |
| Trimurthi Limited | 1.95 Million INR | -36683.086% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | -138.905% |
| Norris Medicines Limited | 29.36 Million INR | -2344.078% |
| Veerhealth Care Limited | 49.57 Million INR | -1347.61% |
| Lactose (India) Limited | 230.3 Million INR | -211.598% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 819.134% |
| Gennex Laboratories Limited | 276.99 Million INR | -159.08% |
| Denis Chem Lab Limited | 596.24 Million INR | -20.36% |
| Colinz Laboratories Limited | 16.35 Million INR | -4287.881% |
| Godavari Drugs Limited | 359.01 Million INR | -99.894% |
| Zenotech Laboratories Limited | 337.19 Million INR | -112.824% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | -6.446% |
| Bharat Parenterals Limited | 989.46 Million INR | 27.472% |
| Coral Laboratories Limited | 332.39 Million INR | -115.901% |
| Evoq Remedies Limited | 47.43 Million INR | -1412.919% |
| Kerala Ayurveda Limited | 447.69 Million INR | -60.298% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 1862.632% |
| Natural Capsules Limited | 557.1 Million INR | -28.817% |
| Auro Laboratories Limited | 249.39 Million INR | -187.757% |